PhD: Neuroscience, Louisiana State University Health Sciences Center
BA: Clinical Biology, Universitat de Barcelona, Barcelona, Spain
Postdoctoral Training: Neuroscience, Louisiana State University Health Sciences Center
Dr. Pacheco-Quinto established his research career examining the risk factors associated with Alzheimer’s disease (AD). His previous work focused on understanding the correlation between the toxic accumulation of the Aβ peptide in AD patients and other cardiovascular risk factors, such as cholesterol, homocysteinemia and hypertension. Dr. Pacheco-Quinto is also investigating the role of ischemic insults in the initiation of AD and other neurological disorders; and working to understand the role of the endothelin system in AD development. Specifically, he is studying how endothelin-converting enzymes (ECEs) regulate brain Aβ levels, and determining whether alterations in the endothelin system may impact Aβ catabolism.
Dr. Pacheco Quinto has a diverse skill set that includes techniques in molecular biology, biochemistry, microscopy and animal modeling. His expertise is a valuable asset to preclinical research at MANA. He is leading a study to develop and test compounds for the treatment of ischemic disorders in neonates, and he collaborates on a study to identify new therapeutic approaches to trigger lung’s intrinsic regeneration potential, in order to treat prematurity-associated chronic lung disease (CLD).